No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
China
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / pharmacokinetics
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Doxorubicin / analogs & derivatives
-
Doxorubicin / pharmacokinetics
-
Humans
-
Lymphoma, Large B-Cell, Diffuse / drug therapy*
-
Lymphoma, Large B-Cell, Diffuse / metabolism
-
Middle Aged
-
Polyethylene Glycols / administration & dosage
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / pharmacokinetics
-
Prednisolone / administration & dosage
-
Prednisolone / adverse effects
-
Prednisolone / pharmacokinetics
-
Progression-Free Survival
-
Rituximab / administration & dosage
-
Rituximab / adverse effects
-
Rituximab / pharmacokinetics
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Vincristine / pharmacokinetics
-
Young Adult
Substances
-
liposomal doxorubicin
-
Polyethylene Glycols
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone